| Serial Number | 87352574 |
| Word Mark | TEVA |
| Filing Date | Tuesday, February 28, 2017 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 29, 2021 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 26, 2017 |
| Indication of Colors claimed | The color(s) dark green, light green, white and gray is/are claimed as a feature of the mark. |
| Description of Mark | The mark consists of a light green design that begins at the bottom left hand corner and rises up to the upper right hand corner. This light green continues in a straight light across the top. There are 2 darker green half circles at the bottom right hand corner that when they intersect make a dark green. In the dark green intersection at the bottom right hand corner is the word "teva" in lower case white letters. The "v" in the word "teva" is formed by 2 leaf shapes. The color white also appears in the rectangle created by the gray outlining the entire mark. The entire mark is outlined by a thin gray line. |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system |
| Translation of Words in Mark | The English translation of "TEVA" in the mark is "NATURE". |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 7, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Teva Pharmaceutical Industries Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Jerusalem 91010 IL |
| Party Name | Teva Pharmaceutical Industries Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Jerusalem 91010 IL |
| Event Date | Event Description |
| Monday, March 29, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 29, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, August 22, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 21, 2020 | EXTENSION 5 GRANTED |
| Thursday, August 13, 2020 | EXTENSION 5 FILED |
| Tuesday, August 18, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, August 13, 2020 | TEAS EXTENSION RECEIVED |
| Saturday, February 29, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 19, 2020 | EXTENSION 4 GRANTED |
| Wednesday, February 19, 2020 | EXTENSION 4 FILED |
| Wednesday, February 19, 2020 | TEAS EXTENSION RECEIVED |
| Wednesday, February 19, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, August 15, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 13, 2019 | EXTENSION 3 GRANTED |
| Tuesday, August 13, 2019 | EXTENSION 3 FILED |
| Tuesday, August 13, 2019 | TEAS EXTENSION RECEIVED |
| Friday, February 15, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 13, 2019 | EXTENSION 2 GRANTED |
| Wednesday, February 13, 2019 | EXTENSION 2 FILED |
| Wednesday, February 13, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, August 15, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 13, 2018 | EXTENSION 1 GRANTED |
| Monday, August 13, 2018 | EXTENSION 1 FILED |
| Monday, August 13, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, February 20, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 26, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 26, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 6, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, November 17, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 17, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Friday, November 17, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, November 17, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Friday, November 17, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, November 14, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, November 14, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 14, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 26, 2017 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Friday, May 26, 2017 | PRIORITY ACTION E-MAILED |
| Friday, May 26, 2017 | PRIORITY ACTION WRITTEN |
| Tuesday, May 23, 2017 | ASSIGNED TO EXAMINER |
| Wednesday, March 8, 2017 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, March 7, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, March 3, 2017 | NEW APPLICATION ENTERED IN TRAM |